Skip to main content
. Author manuscript; available in PMC: 2018 Jun 30.
Published in final edited form as: Int J Pharm. 2017 Apr 26;526(1-2):69–76. doi: 10.1016/j.ijpharm.2017.04.053

Fig. 3.

Fig. 3

Characterization of Zol-Ca@bi-lipid NPs prepared with a Zol-Ca@DOPA to DSPE-PEG2k ratio of 20 µg/1 mg. (A) a representative TEM image after negative staining. Nanoparticles with clear core-shell structure are indicated by white arrows (bar = 100 nm); (B) hydrodynamic size distribution of the Zol-Ca@bi-lipid NPs in aqueous suspension.